[Interaction of aminoglycoside antibiotics with human blood erythrocytes]. 1971

G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa
D015643 Erythromycin Ethylsuccinate A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Monomycin,E-Mycin E,EryPed,Erythroped,Eyrthromycin Ethyl Succinate,Pediamycin,Wyamycin E,EMycin E,Ethyl Succinate, Eyrthromycin,Ethylsuccinate, Erythromycin,Succinate, Eyrthromycin Ethyl

Related Publications

G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
January 1979, Giornale italiano di chemioterapia,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
August 1974, Orvosi hetilap,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
January 1987, Drugs under experimental and clinical research,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
May 1979, The Journal of antibiotics,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
December 1978, The Journal of antibiotics,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
July 1989, Journal of chemotherapy (Florence, Italy),
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
December 1976, Biulleten' eksperimental'noi biologii i meditsiny,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
September 1974, The Journal of antibiotics,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
May 1988, Journal of pharmaceutical sciences,
G Ia Kivman, and I Ia Geĭtman, and A G Sharafeev
January 1982, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!